Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Insmed Inc has a consensus price target of $96.21 based on the ratings of 21 analysts. The high is $120 issued by HC Wainwright & Co. on June 11, 2025. The low is $42 issued by Wolfe Research on February 15, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Mizuho, and RBC Capital on June 11, 2025, respectively. With an average price target of $109.33 between Goldman Sachs, Mizuho, and RBC Capital, there's an implied 10.44% upside for Insmed Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/11/2025 | Buy Now | 13.13% | Goldman Sachs | Andrea Tan39% | $100 → $112 | Maintains | Buy | Get Alert |
06/11/2025 | Buy Now | 11.11% | Mizuho | Graig Suvannavejh51% | $96 → $110 | Maintains | Outperform | Get Alert |
06/11/2025 | Buy Now | 7.07% | RBC Capital | Leonid Timashev39% | $99 → $106 | Maintains | Outperform | Get Alert |
06/11/2025 | Buy Now | 3.03% | Morgan Stanley | Matthew Harrison60% | $90 → $102 | Maintains | Overweight | Get Alert |
06/11/2025 | Buy Now | 10.1% | B of A Securities | Jason Zemansky77% | $94 → $109 | Maintains | Buy | Get Alert |
06/11/2025 | Buy Now | 20.2% | Wells Fargo | Tiago Fauth47% | $107 → $119 | Maintains | Overweight | Get Alert |
06/11/2025 | Buy Now | 21.21% | HC Wainwright & Co. | Andrew Fein45% | $90 → $120 | Maintains | Buy | Get Alert |
06/10/2025 | Buy Now | 16.16% | Leerink Partners | Joseph Schwartz64% | $100 → $115 | Maintains | Outperform | Get Alert |
05/13/2025 | Buy Now | 6.06% | Jefferies | Kelly Shi41% | → $105 | Initiates | → Buy | Get Alert |
05/09/2025 | Buy Now | 10.1% | UBS | Trung Huynh42% | $110 → $109 | Maintains | Buy | Get Alert |
04/22/2025 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
03/20/2025 | Buy Now | -3.03% | B of A Securities | Jason Zemansky77% | $92 → $96 | Maintains | Buy | Get Alert |
03/19/2025 | Buy Now | 1.01% | RBC Capital | Leonid Timashev39% | $100 → $100 | Reiterates | Outperform → Outperform | Get Alert |
03/06/2025 | Buy Now | 11.11% | UBS | Trung Huynh42% | $105 → $110 | Maintains | Buy | Get Alert |
02/25/2025 | Buy Now | 1.01% | RBC Capital | Leonid Timashev39% | → $100 | Initiates | → Outperform | Get Alert |
02/25/2025 | Buy Now | 2.02% | Guggenheim | Vamil Divan74% | $101 → $101 | Reiterates | Buy → Buy | Get Alert |
02/24/2025 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
02/21/2025 | Buy Now | 9.09% | Truist Securities | Nicole Germino64% | $105 → $108 | Maintains | Buy | Get Alert |
02/21/2025 | Buy Now | -3.03% | Stifel | Stephen Willey54% | $97 → $96 | Maintains | Buy | Get Alert |
02/21/2025 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
02/20/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim60% | — | Reiterates | Overweight → Overweight | Get Alert |
02/19/2025 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim60% | — | Reiterates | Overweight → Overweight | Get Alert |
02/19/2025 | Buy Now | 8.08% | Wells Fargo | Tiago Fauth47% | $85 → $107 | Maintains | Overweight | Get Alert |
02/11/2025 | Buy Now | -2.02% | Stifel | Stephen Willey54% | $88 → $97 | Maintains | Buy | Get Alert |
02/07/2025 | Buy Now | -7.07% | JP Morgan | Jessica Fye67% | $83 → $92 | Maintains | Overweight | Get Alert |
02/07/2025 | Buy Now | 2.02% | Guggenheim | Vamil Divan74% | $95 → $101 | Maintains | Buy | Get Alert |
02/06/2025 | Buy Now | -9.09% | Morgan Stanley | Matthew Harrison60% | $85 → $90 | Maintains | Overweight | Get Alert |
11/22/2024 | Buy Now | -16.16% | JP Morgan | Jessica Fye67% | $74 → $83 | Maintains | Overweight | Get Alert |
11/01/2024 | Buy Now | 6.06% | Truist Securities | Nicole Germino64% | $100 → $105 | Reiterates | Buy → Buy | Get Alert |
11/01/2024 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
10/11/2024 | Buy Now | 1.01% | Truist Securities | Nicole Germino64% | $85 → $100 | Maintains | Buy | Get Alert |
10/09/2024 | Buy Now | -13.13% | B of A Securities | Jason Zemansky77% | $84 → $86 | Maintains | Buy | Get Alert |
10/03/2024 | Buy Now | -25.25% | JP Morgan | Jessica Fye67% | $72 → $74 | Maintains | Overweight | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Josh Schimmer57% | — | Reiterates | → Overweight | Get Alert |
08/29/2024 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
08/12/2024 | Buy Now | -14.14% | Truist Securities | Nicole Germino64% | $88 → $85 | Maintains | Buy | Get Alert |
08/12/2024 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | Buy Now | -14.14% | Wells Fargo | Tiago Fauth47% | $77 → $85 | Maintains | Overweight | Get Alert |
08/09/2024 | Buy Now | -1.01% | TD Cowen | Ritu Baral40% | $75 → $98 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | -15.15% | UBS | Trung Huynh42% | $78 → $84 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | -11.11% | Stifel | Stephen Willey54% | $74 → $88 | Maintains | Buy | Get Alert |
07/12/2024 | Buy Now | -14.14% | Morgan Stanley | Matthew Harrison60% | $60 → $85 | Maintains | Overweight | Get Alert |
07/10/2024 | Buy Now | 3.03% | Goldman Sachs | Andrea Tan39% | $74 → $102 | Maintains | Buy | Get Alert |
07/09/2024 | Buy Now | -4.04% | Guggenheim | Vamil Divan74% | $70 → $95 | Maintains | Buy | Get Alert |
07/08/2024 | Buy Now | -9.09% | HC Wainwright & Co. | Andrew Fein45% | $70 → $90 | Maintains | Buy | Get Alert |
07/05/2024 | Buy Now | -16.16% | B of A Securities | Jason Zemansky77% | $83 → $83 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | -29.29% | HC Wainwright & Co. | Andrew Fein45% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
07/01/2024 | Buy Now | -11.11% | Truist Securities | Nicole Germino64% | $68 → $88 | Maintains | Buy | Get Alert |
06/28/2024 | Buy Now | -16.16% | B of A Securities | Jason Zemansky77% | $62 → $83 | Maintains | Buy | Get Alert |
06/21/2024 | Buy Now | -24.24% | Evercore ISI Group | Josh Schimmer57% | $42 → $75 | Maintains | Outperform | Get Alert |
06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim60% | — | Reiterates | → Overweight | Get Alert |
06/20/2024 | Buy Now | -27.27% | JP Morgan | Jessica Fye67% | $55 → $72 | Maintains | Overweight | Get Alert |
06/07/2024 | Buy Now | -17.17% | Mizuho | Graig Suvannavejh51% | $36 → $82 | Maintains | Buy | Get Alert |
06/05/2024 | Buy Now | -25.25% | Stifel | Stephen Willey54% | $67 → $74 | Maintains | Buy | Get Alert |
05/31/2024 | Buy Now | -32.32% | Stifel | Stephen Willey54% | $39 → $67 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -32.32% | TD Cowen | Ritu Baral40% | $45 → $67 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -41.41% | UBS | Trung Huynh42% | $46 → $58 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -25.25% | Goldman Sachs | Andrea Tan39% | $49 → $74 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -22.22% | Wells Fargo | Tiago Fauth47% | $55 → $77 | Maintains | Overweight | Get Alert |
05/29/2024 | Buy Now | -31.31% | Truist Securities | Nicole Germino64% | $48 → $68 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -36.36% | Barclays | Leon Wang64% | $40 → $63 | Maintains | Overweight | Get Alert |
05/29/2024 | Buy Now | -44.44% | JP Morgan | Jessica Fye67% | $36 → $55 | Maintains | Overweight | Get Alert |
05/29/2024 | Buy Now | -37.37% | B of A Securities | Jason Zemansky77% | $40 → $62 | Maintains | Buy | Get Alert |
05/29/2024 | Buy Now | -29.29% | HC Wainwright & Co. | Andrew Fein45% | $52 → $70 | Maintains | Buy | Get Alert |
05/28/2024 | Buy Now | -39.39% | Morgan Stanley | Matthew Harrison60% | $43 → $60 | Maintains | Overweight | Get Alert |
05/28/2024 | Buy Now | -59.6% | B of A Securities | Jason Zemansky77% | $40 → $40 | Maintains | Buy | Get Alert |
05/16/2024 | Buy Now | -51.52% | Truist Securities | Nicole Germino64% | $48 → $48 | Maintains | Buy | Get Alert |
05/15/2024 | Buy Now | -50.51% | Goldman Sachs | Andrea Tan39% | $40 → $49 | Maintains | Buy | Get Alert |
05/14/2024 | Buy Now | -47.47% | HC Wainwright & Co. | Andrew Fein45% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | -63.64% | Mizuho | Graig Suvannavejh51% | $35 → $36 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | -56.57% | Morgan Stanley | Matthew Harrison60% | $40 → $43 | Maintains | Overweight | Get Alert |
04/23/2024 | Buy Now | -51.52% | Truist Securities | Nicole Germino64% | → $48 | Initiates | → Buy | Get Alert |
04/11/2024 | Buy Now | -59.6% | Barclays | Leon Wang64% | $37 → $40 | Maintains | Overweight | Get Alert |
04/01/2024 | Buy Now | -44.44% | Wells Fargo | Tiago Fauth47% | $55 → $55 | Maintains | Overweight | Get Alert |
02/27/2024 | Buy Now | -45.45% | Guggenheim | Vamil Divan74% | $52 → $54 | Maintains | Buy | Get Alert |
02/27/2024 | Buy Now | -53.54% | UBS | Trung Huynh42% | → $46 | Initiates | → Buy | Get Alert |
02/23/2024 | Buy Now | -59.6% | B of A Securities | Jason Zemansky77% | $37 → $40 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | -57.58% | Wolfe Research | Andy Chen48% | → $42 | Initiates | → Outperform | Get Alert |
11/20/2023 | Buy Now | -63.64% | JP Morgan | Jessica Fye67% | → $36 | Reinstates | → Overweight | Get Alert |
10/27/2023 | Buy Now | -64.65% | Mizuho | Graig Suvannavejh51% | $33 → $35 | Maintains | Buy | Get Alert |
09/21/2023 | Buy Now | -45.45% | Cantor Fitzgerald | Jennifer Kim60% | $46 → $54 | Maintains | Overweight | Get Alert |
09/19/2023 | Buy Now | -53.54% | Cantor Fitzgerald | Jennifer Kim60% | → $46 | Reiterates | Overweight → Overweight | Get Alert |
09/07/2023 | Buy Now | -57.58% | Evercore ISI Group | Josh Schimmer57% | $32 → $42 | Maintains | Outperform | Get Alert |
09/06/2023 | Buy Now | -66.67% | Mizuho | Graig Suvannavejh51% | $30 → $33 | Maintains | Buy | Get Alert |
09/06/2023 | Buy Now | -62.63% | B of A Securities | Jason Zemansky77% | $35 → $37 | Maintains | Buy | Get Alert |
09/06/2023 | Buy Now | -47.47% | HC Wainwright & Co. | Andrew Fein45% | → $52 | Reiterates | Buy → Buy | Get Alert |
09/05/2023 | Buy Now | -47.47% | Guggenheim | Vamil Divan74% | $50 → $52 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | Buy Now | -64.65% | Stifel | Stephen Willey54% | $33 → $35 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | -58.59% | Morgan Stanley | Matthew Harrison60% | $41 → $41 | Reiterates | Overweight → Overweight | Get Alert |
08/04/2023 | Buy Now | -47.47% | HC Wainwright & Co. | Andrew Fein45% | → $52 | Reiterates | Buy → Buy | Get Alert |
07/26/2023 | Buy Now | -69.7% | Mizuho | Graig Suvannavejh51% | $28 → $30 | Maintains | Buy | Get Alert |
07/26/2023 | Buy Now | -49.49% | Guggenheim | Vamil Divan74% | → $50 | Initiates | → Buy | Get Alert |
05/09/2023 | Buy Now | -47.47% | HC Wainwright & Co. | Andrew Fein45% | → $52 | Reiterates | → Buy | Get Alert |
02/24/2023 | Buy Now | -53.54% | Cantor Fitzgerald | Jennifer Kim60% | $49 → $46 | Maintains | Overweight | Get Alert |
02/24/2023 | Buy Now | -53.54% | Credit Suisse | Judah Frommer64% | → $46 | Reiterates | → Outperform | Get Alert |
02/24/2023 | Buy Now | -47.47% | HC Wainwright & Co. | Andrew Fein45% | → $52 | Reiterates | → Buy | Get Alert |
01/20/2023 | Buy Now | -64.65% | Barclays | Leon Wang64% | $37 → $35 | Maintains | Overweight | Get Alert |
01/09/2023 | Buy Now | -60.61% | Goldman Sachs | Andrea Tan39% | $44 → $39 | Maintains | Buy | Get Alert |
12/09/2022 | Buy Now | -71.72% | Mizuho | Graig Suvannavejh51% | → $28 | Initiates | → Buy | Get Alert |
12/08/2022 | Buy Now | -62.63% | Barclays | Leon Wang64% | → $37 | Initiates | → Overweight | Get Alert |
The latest price target for Insmed (NASDAQ:INSM) was reported by Goldman Sachs on June 11, 2025. The analyst firm set a price target for $112.00 expecting INSM to rise to within 12 months (a possible 13.13% upside). 47 analyst firms have reported ratings in the last year.
The latest analyst rating for Insmed (NASDAQ:INSM) was provided by Goldman Sachs, and Insmed maintained their buy rating.
There is no last upgrade for Insmed
There is no last downgrade for Insmed.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Insmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Insmed was filed on June 11, 2025 so you should expect the next rating to be made available sometime around June 11, 2026.
While ratings are subjective and will change, the latest Insmed (INSM) rating was a maintained with a price target of $100.00 to $112.00. The current price Insmed (INSM) is trading at is $99.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.